Please wait…

09/11/2018 00:35:41
A A | Print

Studie: Deutschland in Spitzengruppe bei medizinischem Personal


SEATTLE (dpa-AFX) - Deutschland, Island und Kuba haben etwas gemeinsam: Sie gehören zu den 15 Ländern der Welt mit dem meisten medizinischen Personal. Das geht aus einer der weltweit größten Gesundheitsstudien hervor, die in der britischen Fachzeitschrift "The Lancet" veröffentlicht wurde. Auf den letzten Platz kam demnach das westafrikanische Land Benin. Berücksichtigt wurde die Zahl der Ärzte, Krankenschwestern und Hebammen im Vergleich zur Einwohnerzahl. Einen Rückschluss auf die Qualität der medizinischen Versorgung lasse die Studie mit Daten aus dem Jahr 2017 jedoch nicht zu, betonen die Autoren.

Sorgen bereitet den Wissenschaftlern, dass fast die Hälfte aller 195 untersuchten Länder mit einem Mangel an medizinischem Personal zu kämpfen hat. Hier standen im vergangenen Jahr weniger als zehn Ärzte und weniger als 30 Krankenschwestern und Hebammen pro 10 000 Einwohner zur Verfügung. Die international großen Unterschiede in der Entwicklung seien beunruhigend, so die Forscher.

Die Studie "Global Burden of Disease" wurde erstmals Anfang der Neunzigerjahre durchgeführt. Mittlerweile sind über 3500 Wissenschaftler aus mehr als 140 Ländern an dem Projekt beteiligt./jki/DP/jha

Login required

Username or email:
Password:

To use this function please log-in
If you haven't got an account on boerse-frankfurt.de, you have the opportunity to register regist here for free.

add instrument

pagehit

The following Disclaimer and Information has been prepared by Voltabox AG (the “Issuer”) for the purpose of publishing THE securities prospectus by the issuer. Deutsche Boerse AG does not assume any responsibility for the content of the issuer`s Disclaimer and information.

 

Important Information


 

The information contained on the following web pages is directed only at persons who are resident of or domiciled in the Federal Republic of Germany (“Germany”) or the Grand Duchy of Luxembourg (“Luxembourg”). The following information does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities. No offer of securities of the Issuer is being, or will be, made to the public outside Germany and Luxembourg. The offer in Germany and Luxembourg is being made solely on the basis of the securities prospectus (including any amendments thereto) which has been approved by the German Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and which has been published on the Issuer’s website. Any investment decision regarding the publicly offered securities of the Issuer should only be made on the basis of the securities prospectus. The securities prospectus is available free of charge from the Issuer (Artegastraße 1, 33129 Delbrück, Germany; Tel.: +49 (0)5250 9930-900; Fax: +49 (0)5250 9762-102) and on the Issuer’s website (www.voltabox.ag).



The information contained on the following web pages is not an offer of securities for sale or a solicitation of an offer to purchase securities in the United States of America (“United States”), Canada, Australia or Japan. The Issuer’s shares, and the securities offered in the course of the offer, have not been and will not be registered under the US Securities Act of 1933, as amended (“Securities Act”), or with any other securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold or delivered within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. The Issuer does not intend to register the offer or parts thereof in the United States or make an offer to the public in the United States, Canada, Australia or Japan.



The information contained on the following web pages is not for distribution to persons who are located in the United States, Canada, Australia or Japan or any other jurisdiction where the offer of the securities to the public is not taking place. Any violation of these restrictions may constitute a breach of the securities laws of these countries. The copying, forwarding or other transmission of the content of the following web pages is prohibited.

By clicking the "I AGREE" button below, you warrant that (i) you have read and accepted the foregoing information and restrictions in full and (ii) you are a resident of or domiciled in Germany or Luxembourg, and (iii) you agree not to distribute or forward the information contained on the following web pages to any person who is not a resident of or domiciled in Germany or Luxembourg.

 


We regret that, due to regulatory restrictions, we are unable to provide you with access to the following web pages.